William R. Miller
Président chez The English-Speaking Union of the United States
Profil
William R.
Miller is currently the Chairman of The English-Speaking Union of the United States, Director of Opera Orchestra of New York, Inc., Member of the University of Oxford, and Trustee of Manhattan School of Music.
Previously, he was the Vice Chairman of Bristol Myers Squibb Co. from 1964 to 1991, Chairman of Vion Pharmaceuticals, Inc. from 1995 to 2010, Chairman of CytoSorbents Corp.
in 2007-2008, and Chairman of MelaRx, Inc. in 1995.
He also served as a Director of ImClone LLC, Transkaryotic Therapies, Inc., and Elusys Therapeutics, Inc. Additionally, he was a Board Member & Managing Director of Metropolitan Opera Association, Inc. and a Director of Lincoln Center for the Performing Arts, Inc. Mr. Miller received his undergraduate and graduate degrees from the University of Oxford.
Postes actifs de William R. Miller
| Sociétés | Poste | Début |
|---|---|---|
| Manhattan School of Music | Directeur/Membre du Conseil | - |
Opera Orchestra of New York, Inc.
 Opera Orchestra of New York, Inc. Movies/EntertainmentConsumer Services Opera Orchestra of New York, Inc. engages in the performance of opera in a concert form. It focuses solely on the fit between the voice and the role of artists. The company was founded by Eve Queler and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
| University of Oxford | Corporate Officer/Principal | - |
| The English-Speaking Union of the United States | Président | - |
Anciens postes connus de William R. Miller
| Sociétés | Poste | Fin |
|---|---|---|
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Président | 08/04/2010 |
| CYTOSORBENTS CORPORATION | Président | 31/12/2008 |
| MelaRx, Inc. | Président | 01/04/1995 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Membre du Conseil | 01/01/1991 |
Lincoln Center for the Performing Arts, Inc.
 Lincoln Center for the Performing Arts, Inc. Movies/EntertainmentConsumer Services Lincoln Center for the Performing Arts, Inc. provides entertainment services. It offers dance, music, film, opera, theater, family, and festivals and programs. The company was founded by Dwight D. Eisenhower on May 14, 1959 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de William R. Miller
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CYTOSORBENTS CORPORATION | Health Technology |
| Entreprise privées | 9 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Metropolitan Opera Association, Inc.
 Metropolitan Opera Association, Inc. Movies/EntertainmentConsumer Services Metropolitan Opera Association, Inc. organizes and performs opera shows in its residence at the Lincoln Center of Performing Arts. The firm offers services in association with sponsors, such as Texaco. It produces radio, television and compact disk recordings of the performances and distributes them around the world. The company was founded in 1883 and is headquartered in New York, NY. | Consumer Services |
Lincoln Center for the Performing Arts, Inc.
Lincoln Center for the Performing Arts, Inc. Movies/EntertainmentConsumer Services Lincoln Center for the Performing Arts, Inc. provides entertainment services. It offers dance, music, film, opera, theater, family, and festivals and programs. The company was founded by Dwight D. Eisenhower on May 14, 1959 and is headquartered in New York, NY. | Consumer Services |
Opera Orchestra of New York, Inc.
Opera Orchestra of New York, Inc. Movies/EntertainmentConsumer Services Opera Orchestra of New York, Inc. engages in the performance of opera in a concert form. It focuses solely on the fit between the voice and the role of artists. The company was founded by Eve Queler and is headquartered in New York, NY. | Consumer Services |
| The English-Speaking Union of the United States | |
| MelaRx, Inc. |
